Literature DB >> 11408058

Novel cell lines established from a human myxoid malignant fibrous histiocytoma arising in the uterus.

Y Kiyozuka1, H Nakagawa, Y Uemura, H Senzaki, A Yamamoto, T Noguchi, H Mizuta, K Nakanishi, S Nakano, A Tsubura.   

Abstract

Two cell lines (Nara-H and Nara-F) with different phenotypes were established from a myxoid MFH of the uterus. In vitro, Nara-F grew in sheets showing a storiform arrangement and Nara-H in raised colonies. Although tumors generated in nude mice shared similar morphological features of abundant myxoid tumor in Nara-H and -F, the pleomorphic component was conspicuous in Nara-F. Both cell lines produced hyaluronic-acid but CD44 was expressed only in Nara-H. Estrogen receptor alpha (ER alpha) and progesterone receptor (PgR) were detected in Nara-H. Nara-F was positive for ER beta and PgR. Among hormonal agents, the response to the anti-estrogen tamoxifen was more sensitive than progesterone agents. This report illustrates the characteristics of these newly established cell lines, and presents the possibility of an adjuvant hormonal therapy for MFH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408058     DOI: 10.1016/s0165-4608(00)00413-1

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization.

Authors:  Jun Nishio; Hiroshi Iwasaki; Kazuki Nabeshima; Masako Ishiguro; Teruto Isayama; Masatoshi Naito
Journal:  J Exp Clin Cancer Res       Date:  2010-11-24

2.  Transcutaneous application of carbon dioxide (CO2) induces mitochondrial apoptosis in human malignant fibrous histiocytoma in vivo.

Authors:  Yasuo Onishi; Teruya Kawamoto; Takeshi Ueha; Kenta Kishimoto; Hitomi Hara; Naomasa Fukase; Mitsunori Toda; Risa Harada; Masaya Minoda; Yoshitada Sakai; Masahiko Miwa; Masahiro Kurosaka; Toshihiro Akisue
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

3.  The combination of rapamycin and MAPK inhibitors enhances the growth inhibitory effect on Nara-H cells.

Authors:  Osamu Nakamura; Toshiaki Hitora; Yoshiki Yamagami; Masaki Mori; Hideki Nishimura; Ryosuke Horie; Konosuke Yamaguchi; Tetsuji Yamamoto
Journal:  Int J Mol Med       Date:  2014-03-27       Impact factor: 4.101

Review 4.  Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.

Authors:  Silvia Vanni; Alessandro De Vita; Lorena Gurrieri; Valentina Fausti; Giacomo Miserocchi; Chiara Spadazzi; Chiara Liverani; Claudia Cocchi; Chiara Calabrese; Alberto Bongiovanni; Nada Riva; Laura Mercatali; Federica Pieri; Roberto Casadei; Enrico Lucarelli; Toni Ibrahim
Journal:  Ther Adv Med Oncol       Date:  2022-06-28       Impact factor: 5.485

5.  Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS.

Authors:  Masaya Minoda; Teruya Kawamoto; Takeshi Ueha; Etsuko Kamata; Masayuki Morishita; Risa Harada; Mitsunori Toda; Yasuo Onishi; Hitomi Hara; Masahiro Kurosaka; Toshihiro Akisue
Journal:  Int J Oncol       Date:  2015-07-09       Impact factor: 5.884

6.  'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells.

Authors:  Mitsunori Toda; Teruya Kawamoto; Takeshi Ueha; Kenta Kishimoto; Hitomi Hara; Naomasa Fukase; Yasuo Onishi; Risa Harada; Masaya Minoda; Masahiro Kurosaka; Toshihiro Akisue
Journal:  Int J Oncol       Date:  2013-06-28       Impact factor: 5.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.